

CJC-1295 No Dac (10mg)
$87.00 Original price was: $87.00.$78.00Current price is: $78.00.
Contents: Lyophilized Powder in 3ml vial
Requires reconstitution with bacteriostatic water
Rigorous Third-Party Testing
Every batch of our research chemicals and peptides undergoes third-party testing.
- Description
- 3rd Party Lab Testing
Description
CJC-1295 No DAC
Lyophilized Powder | Third-Party Tested | USA-Manufactured
In Stock | Free Shipping on Orders Over $150
Product Specifications
- Peptide Name: CJC-1295 No DAC
- Molecular Formula: C152H252N44O42
- Molecular Weight: ~3367.88 g/mol
- CAS Number: 863288-34-0
- Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
- Purity: ≥99% (HPLC verified)
- Form: Lyophilized powder
- Storage: -20°C (long-term) | 2–8°C (short-term) | Protect from light
- Shelf Life: Up to 12 months when stored sealed and dry
Compound Overview
CJC-1295 No DAC is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) that lacks the drug-affinity complex (DAC) modification. Its linear amino acid sequence and C-terminal amidation contribute to defined biochemical properties and analytical detection profiles in laboratory workflows.
In research settings, CJC-1295 No DAC is evaluated for receptor interaction characterization, peptide stability profiling, and analytical quantification using chromatographic and mass spectrometry techniques under controlled in vitro and preclinical animal model conditions. Experimental literature describes its classification within GHRH-class peptide analog research systems. All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for CJC-1295 No DAC as a research compound.
Published Preclinical Research
Published literature describes GHRH-class peptide analogs such as CJC-1295 No DAC as defined research compounds investigated within controlled experimental systems.
- Structural characterization and receptor interaction profiling in preclinical models
- Analytical detection using immunoaffinity purification and LC-MS methodologies
- Peptide stability and degradation profiling in biological matrices
- Comparative evaluation of long-acting GHRH analogs in controlled research workflows
All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for CJC-1295 No DAC.
Research Applications
- Peptide identity confirmation in laboratory analytical workflows
- Mass spectrometry reference standard calibration
- Receptor interaction modeling in vitro
- Chromatographic method development for peptide analog detection
- Comparative evaluation of GHRH analog sequences
Physical Specifications
- Vial Size: 3 mL sterile vial
- Fill: 10mg
- Appearance: White to off-white lyophilized powder
- Reconstitution Volume: Researcher-determined under validated laboratory protocols
- Post-Reconstitution Storage: 2–8°C, use within 30 days
- Solubility: Water-based laboratory solvents
Compare to Related Compounds
Tesamorelin
- CJC-1295 No DAC is a GHRH analog lacking DAC modification, whereas Tesamorelin is a stabilized full-length GHRH analog with an N-terminal modification that influences peptide stability.
- These compounds are differentiated in laboratory characterization by sequence length, structural modification, and analytical detection profiles.
Ipamorelin
- CJC-1295 No DAC is a GHRH receptor–targeting peptide analog, whereas Ipamorelin is a short secretagogue-class peptide used in growth hormone secretagogue receptor research workflows.
- Analytical differentiation is based on primary sequence architecture and receptor pathway classification in controlled laboratory systems.
Handling & Storage
Lyophilized Stability:
When stored sealed in a dry environment protected from light, lyophilized peptide material may maintain chemical stability for up to 12 months at controlled room temperature. For maximum long-term preservation, storage at -20°C is recommended.
Post-Reconstitution Stability:
Following reconstitution under sterile laboratory conditions, the solution may maintain stability for up to 30 days when stored at 2–8°C. Minimize repeated freeze–thaw cycles and protect from light to preserve peptide integrity.
Handling:
Allow vial to equilibrate to room temperature before opening to prevent moisture condensation. Use sterile technique throughout preparation.
Certificate of Analysis & Third-Party Testing
Every batch of BioEdge CJC-1295 No DAC undergoes independent third-party testing prior to release. Testing is performed by ISO-accredited laboratories with results available on each product page.
| Identity Confirmation | Mass Spectrometry (MS) |
| Purity Assessment | High-Performance Liquid Chromatography (HPLC) |
| Minimum Purity Acceptance | ≥99% |
| Heavy Metals | ICP-MS panel |
| Sterility | USP <71> Sterility Testing |
| COA Format | Batch-specific test results, downloadable on product page |
To view testing results, scroll to the 3rd Party Testing section located below the product image.
Why Researchers Choose BioEdge for CJC-1295 No DAC
Batch-specific COA from an independent lab. Not a generic PDF recycled across products. Every vial of CJC-1295 No DAC is backed by independent third-party laboratory testing, with a Certificate of Analysis available for review on our product page. HPLC confirms purity. Mass spectrometry confirms molecular identity. The COA corresponds to the specific batch you receive.
USA lyophilization. Many vendors import pre-filled vials from overseas and relabel them. BioEdge sources API and performs lyophilization within the United States, maintaining direct quality control over the final product.
No filler compounds. BioEdge CJC-1295 No DAC is pure lyophilized peptide. No mannitol, no bulking agents, no unnecessary excipients.
Same-day shipping. Domestic orders placed before 3pm ship the same day. Free shipping on orders over $150.
Frequently Asked Questions
What is CJC-1295 No DAC?
CJC-1295 No DAC is a synthetic peptide analog of growth hormone-releasing hormone supplied exclusively for laboratory research use.
What is the CAS number for CJC-1295 No DAC?
863288-34-0
How should CJC-1295 No DAC be stored?
Store sealed in a dry environment protected from light. For maximum long-term preservation, storage at -20°C is recommended.
Is CJC-1295 No DAC third-party tested?
Yes. Every batch undergoes independent third-party testing prior to release.
Where can I access the COA for CJC-1295 No DAC?
COAs are available below the product image in the 3rd Party Testing section on the product page.
Is CJC-1295 No DAC FDA approved?
BioEdge CJC-1295 No DAC is sold strictly as a research compound for in vitro laboratory use. It has not been evaluated or approved by the FDA for any human use in this form. All products sold by BioEdge Research Labs are for laboratory and research purposes only.
Do you ship CJC-1295 No DAC within the USA?
Yes. BioEdge Research Labs is a USA based supplier with same day domestic shipping on orders placed before 3pm Eastern. Free shipping on orders over $150.
Can I get bulk pricing on CJC-1295 No DAC?
Yes. Contact BioEdge Research Labs directly for institutional and bulk research pricing.
Published References
1. Veldhuis JD, et al. “Pulsatile Secretion of Growth Hormone (GH) Persists during Continuous Elevation of GH Concentrations after Administration of a Long-Acting GH-Releasing Hormone Analog (CJC-1295).” The Journal of Clinical Endocrinology & Metabolism. 2006;91(12):4792-4797. Link
2. Frohman LA, et al. “Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.” American Journal of Physiology-Endocrinology and Metabolism. 2006;291(6):E1290-E1294. Link
3. Mayo KE, et al. “Growth hormone-releasing hormone receptor activation and signal transduction mechanisms.” Endocrinology. 2005;146(7):3052-3060. Link
4. Smith RG, et al. “Growth hormone secretagogue receptor interactions and signaling pathways in preclinical systems.” Peptides. 2009;30(6):1136-1143. Link
RESEARCH USE ONLY Disclaimer
RESEARCH USE ONLY. CJC-1295 No DAC is sold exclusively for in vitro laboratory and research purposes. This product is not intended for human or animal consumption, clinical use, or therapeutic application. It has not been evaluated by the Food and Drug Administration (FDA) for safety, efficacy, or any medical purpose. Purchase and use of this product confirms the buyer will use it only in qualified research settings, in compliance with all applicable federal, state, and local regulations. BioEdge Research Labs is a chemical supplier, not a compounding pharmacy or clinical facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. BioEdge Research Labs makes no claims regarding therapeutic, diagnostic, or clinical applications of this compound.







